Literature DB >> 4382112

Cholinergic-anticholinergic antagonism in parkinsonism.

R C Duvoisin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4382112     DOI： 10.1001/archneur.1967.00470260014002

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  60 in total

Review 1.  Pharmacological treatment of Parkinson's disease.

Authors:  A Münchau; K P Bhatia
Journal:  Postgrad Med J       Date:  2000-10       Impact factor: 2.401

2.  The cerebrospinal fluid choline levels in patients with Huntington's chorea. Negative effect of haloperidol treatment.

Authors:  S Consolo; H Ladinsky; S Bianchi; T Caraceni
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1977-05-16

3.  Enhanced striatal cholinergic neuronal activity mediates L-DOPA-induced dyskinesia in parkinsonian mice.

Authors:  Yunmin Ding; Lisa Won; Jonathan P Britt; Sean Austin O Lim; Daniel S McGehee; Un Jung Kang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

4.  Editorial: Miracle cures in Parkinson's disease.

Authors: 
Journal:  Br Med J       Date:  1975-07-05

5.  Cholinergic interneurons control the excitatory input to the striatum.

Authors:  Pavel Pakhotin; Enrico Bracci
Journal:  J Neurosci       Date:  2007-01-10       Impact factor: 6.167

6.  Effect of oxotremorine on the response of antidromically activated Renshaw cells in decerebrate cats.

Authors:  D K Ganguly; H G Ross; J Haase; S Cleveland
Journal:  Exp Brain Res       Date:  1976-05-10       Impact factor: 1.972

7.  Vacuous jaw movements induced by sub-chronic administration of haloperidol: interactions with scopolamine.

Authors:  R E Steinpreis; P Baskin; J D Salamone
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease.

Authors:  J D Parkes; R C Baxter; C D Marsden; J E Rees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-04       Impact factor: 10.154

9.  Modification of the tremorigenic activity of physostigmine.

Authors:  L M Ambrani; M H Van Woert
Journal:  Br J Pharmacol       Date:  1972-10       Impact factor: 8.739

10.  Pharmacological characterization of performance on a concurrent lever pressing/feeding choice procedure: effects of dopamine antagonist, cholinomimetic, sedative and stimulant drugs.

Authors:  M S Cousins; W Wei; J D Salamone
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.